Medicine and Dentistry
Transforming Growth Factor
100%
Mitogen Activated Protein Kinase 3
58%
Glomerulosclerosis
41%
Doxorubicin
33%
Podocyte
33%
Trametinib
33%
Plasminogen Activator Inhibitor-1
25%
Mechanistic Target of Rapamycin
25%
Albuminuria
25%
Combination Therapy
16%
Collagen
16%
Glomerulus
16%
Proteinuria
16%
Fibrogenesis
16%
Focal Segmental Glomerulosclerosis
16%
Mammalian Target of Rapamycin Complex 2
16%
Messenger RNA
8%
Phosphorylation
8%
Protein
8%
Mediator
8%
Upregulation
8%
Low Drug Dose
8%
Ex Vivo
8%
Fibronectin
8%
Serum Albumin
8%
Rapamycin
8%
Positive Feedback
8%
Monocyte Chemotactic Protein 1
8%
Development
8%
Smooth Muscle Actin
8%
Vimentin
8%
Glomerulopathy
8%
Protein S6
8%
Cells
8%
Marker
8%
Regulatory Mechanism
8%
Feedback System
8%
Growth Factor Receptor
8%
Paracrine Signaling
8%
Pharmacology, Toxicology and Pharmaceutical Science
Transforming Growth Factor
100%
Mitogen Activated Protein Kinase 3
58%
Glomerulosclerosis
41%
Doxorubicin
33%
Trametinib
33%
Mammalian Target of Rapamycin
25%
Albuminuria
25%
Plasminogen Activator Inhibitor 1
25%
Collagen
16%
Proteinuria
16%
Focal Glomerulosclerosis
16%
Mammalian Target of Rapamycin Complex 2
16%
Protein
8%
Messenger RNA
8%
Serum Albumin
8%
Monocyte Chemotactic Protein 1
8%
Fibronectin
8%
Smooth Muscle Actin
8%
Vimentin
8%
Protein S6
8%
Glomerulopathy
8%
Growth Factor Receptor
8%
Mouse
8%
Biochemistry, Genetics and Molecular Biology
Transforming Growth Factor
100%
Podocyte
33%
Plasminogen Activator Inhibitor-1
25%
Trametinib
25%
Mammalian Target of Rapamycin
25%
Fibrogenesis
16%
Focal Segmental Glomerulosclerosis
16%
Mammalian Target of Rapamycin Complex 2
16%
Protein
16%
Collagen
16%
Actin
8%
Phosphorylation
8%
Mediator
8%
Upregulation
8%
Positive Feedback
8%
Monocyte
8%
Low Drug Dose
8%
Fibronectin
8%
Growth Factor Receptor
8%
Serum Albumin
8%
Vimentin
8%
Ribosomal Protein S6
8%
Mouse
8%
Development
8%
Paracrine Signalling
8%
Messenger RNA
8%
Regulatory Mechanism
8%
Transcription
8%
In Vivo Study
8%
Feedback System
8%